As EGFR signaling pathways play an important role in NSCLC [13], understanding their downstream signaling is crucial to better stratify patients, guide therapy choices, and provide insights into resistance mechanisms and putative overcoming strategies. Here, EGFR is linked to non-small cell lung carcinoma.